Prevalence and genotyping of HPV in cervical cancer among Australian women

被引:18
作者
Chen, S [1 ]
O'Sullivan, H
Tabrizi, SN
Fairley, CK
Quinn, MA
Garland, SM
机构
[1] Royal Hosp Women, Dept Microbiol & Infect Dis, Carlton, Vic, Australia
[2] Royal Hosp Women, Dept Oncol, Carlton, Vic, Australia
[3] Monash Univ, Dept Epidemiol & Prevent Med, Prahran, Vic, Australia
关键词
cervical cancer; HPV; tumor histology;
D O I
10.1016/S0020-7292(99)00167-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To investigate the association between HPV DNA detection and histological examination of tumor biopsies from women with cervical cancer. Method: A total of 186 women with cervical cancer were screened for HPV infection using MY09/MY11 primer based PCR. The status of HPV infection was correlated with histological and demographic characteristics by Fisher's exact test or Chi square test. Result: The prevalence of HPV infection in this Australian population was 91.9% (171). Among these 53.8% (100) were HPV type 16, 17.2% (32) HPV type 18, and 21.0% (39) other HPV types. Three significant associations were identified: (1) HPV genotype Is and adenocarcinomas/adenosquamous carcinomas (P < 0.001); (2) HPV DNA negativity and postmenopausal status (P = 0.02); and (3) HPV DNA positivity and lymphocyte infiltration of tumor tissues (P = 0.03). Conclusion: HPV infection is present in the vast majority of cervical cancer patients. However, its presence or genotyping does not seem to have a major influence on the pathogenesis of cervical cancer, such as tumor grade, FIGO staging and metastasis (P > 0.1). (C) 1999 International Federation of Gynecology and Obstetrics.
引用
收藏
页码:163 / 168
页数:6
相关论文
共 30 条
  • [1] *AUSTR I HLTH WELF, 1998, AUSTR I HLTH WELF AS
  • [2] GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE UNIVERSITY-STUDENTS AS DETERMINED BY A PCR-BASED METHOD
    BAUER, HM
    TING, Y
    GREER, CE
    CHAMBERS, JC
    TASHIRO, CJ
    CHIMERA, J
    REINGOLD, A
    MANOS, MM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04): : 472 - 477
  • [3] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [4] Chaouki N, 1998, INT J CANCER, V75, P546, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt
  • [5] 546::AID-IJC9&gt
  • [6] 3.0.CO
  • [7] 2-T
  • [8] CONDON J, 1996, CANC N TERRITORY
  • [9] HUMAN PAPILLOMAVIRUS TYPE-16 DNA IN CERVICAL SMEARS AS PREDICTOR OF HIGH-GRADE CERVICAL-CANCER
    CUZICK, J
    TERRY, G
    HO, L
    HOLLINGWORTH, T
    ANDERSON, M
    [J]. LANCET, 1992, 339 (8799) : 959 - 960
  • [10] FRANCO EL, 1992, CANCER EPIDEM BIOMAR, V1, P499